LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
People with a Nucleus® 7 Sound Processor can now benefit from monitoring and direct control functionality on any compatible Android smartphone via the Nucleus Smart App* New ForwardFocus feature ...
Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback